• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Paradoxical exacerbation of latent interstitial pneumonia by secukinumab in a patient with psoriasis vulgaris.

作者信息

Hayashi M, Igarashi A, Okamura K, Suzuki T

机构信息

Department of Dermatology, Yamagata University Faculty of Medicine, Iida-Nishi 2-2-2, Yamagata, 990-9585, Japan.

Department of Cardiology, Pulmonology and Nephrology, Yamagata University Faculty of Medicine, Iida-Nishi 2-2-2, Yamagata, 990-9585, Japan.

出版信息

Br J Dermatol. 2019 Mar;180(3):684-685. doi: 10.1111/bjd.17424. Epub 2019 Jan 1.

DOI:10.1111/bjd.17424
PMID:30430554
Abstract
摘要

相似文献

1
Paradoxical exacerbation of latent interstitial pneumonia by secukinumab in a patient with psoriasis vulgaris.
Br J Dermatol. 2019 Mar;180(3):684-685. doi: 10.1111/bjd.17424. Epub 2019 Jan 1.
2
Secukinumab-induced interstitial pneumonia in a patient with psoriasis vulgaris.
J Dermatol. 2017 Dec;44(12):e322-e323. doi: 10.1111/1346-8138.13986. Epub 2017 Aug 3.
3
Secukinumab decreases serum Krebs von den Lungen 6 (KL-6) level in patients with psoriasis with elevated serum KL-6 level.司库奇尤单抗可降低血清KL-6水平升高的银屑病患者的血清克雷伯斯-冯-登-卢根6（KL-6）水平。
Br J Dermatol. 2018 Dec;179(6):1396-1397. doi: 10.1111/bjd.16993. Epub 2018 Sep 23.
4
Serum KL-6 levels in Japanese patients with psoriasis treated with secukinumab.接受司库奇尤单抗治疗的日本银屑病患者的血清KL-6水平
J Dermatol. 2019 Apr;46(4):e115-e116. doi: 10.1111/1346-8138.14630. Epub 2018 Sep 11.
5
The risk of interstitial lung disease during biological treatment in Japanese patients with psoriasis.日本银屑病患者生物治疗期间发生间质性肺病的风险。
Clin Exp Dermatol. 2020 Oct;45(7):853-858. doi: 10.1111/ced.14259. Epub 2020 Jun 29.
6
Ixekizumab-induced Interstitial Lung Disease.司库奇尤单抗诱导的间质性肺疾病。
Am J Ther. 2024;31(3):e315-e318. doi: 10.1097/MJT.0000000000001628. Epub 2023 Jul 7.
7
[Drug-induced interstitial lung disease (DILD) during treatment with ustekinumab].[使用优特克单抗治疗期间的药物性间质性肺病（DILD）]
Hautarzt. 2020 Apr;71(4):309-312. doi: 10.1007/s00105-019-04519-9.
8
Respiratory failure due to infliximab induced interstitial lung disease.因英夫利昔单抗导致的间质性肺病引起的呼吸衰竭。
Heart Lung. 2013 Nov-Dec;42(6):480-2. doi: 10.1016/j.hrtlng.2013.07.005. Epub 2013 Aug 19.
9
New-Onset Diffuse Parenchymal Lung Disease in a 52-Year-Old Woman With Ulcerative Colitis.
Gastroenterology. 2020 Feb;158(3):478-479. doi: 10.1053/j.gastro.2019.09.016. Epub 2019 Sep 24.
10
Improvement of the initial stage of interstitial lung disease during psoriasis treatment with secukinumab.使用司库奇尤单抗治疗银屑病期间间质性肺疾病初始阶段的改善情况。
J Dermatol. 2017 Dec;44(12):e328-e329. doi: 10.1111/1346-8138.14026. Epub 2017 Sep 11.

引用本文的文献

1
Drug-Induced Pulmonary Fibrosis: National Database Analysis.药物性肺纤维化：全国数据库分析
Biomedicines. 2024 Nov 21;12(12):2650. doi: 10.3390/biomedicines12122650.
2
Advancements in the Study of Biologic Agents in Comorbidities of Psoriasis: A Literature Review.银屑病合并症生物制剂研究进展：文献综述
Clin Cosmet Investig Dermatol. 2023 Dec 4;16:3487-3495. doi: 10.2147/CCID.S439110. eCollection 2023.
3
A Review of the Safety of Interleukin-17A Inhibitor Secukinumab.白细胞介素-17A抑制剂司库奇尤单抗的安全性综述
Pharmaceuticals (Basel). 2022 Nov 7;15(11):1365. doi: 10.3390/ph15111365.
4
Characteristics of anti-IL-17/23 biologics-induced interstitial pneumonia in patients with psoriasis.银屑病患者抗白细胞介素-17/23 生物制剂诱导的间质性肺炎的特征。
PLoS One. 2021 Jan 7;16(1):e0245284. doi: 10.1371/journal.pone.0245284. eCollection 2021.